Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jun;23(6):892-6.
doi: 10.1128/AAC.23.6.892.

Pharmacokinetics of ceftazidime in male and female volunteers

Pharmacokinetics of ceftazidime in male and female volunteers

D K Sommers et al. Antimicrob Agents Chemother. 1983 Jun.

Abstract

The pharmacokinetic behavior of ceftazidime was assessed after single bolus intravenous injections of 1 g to 12 male and 12 female volunteers. The kinetic handling of the drug was essentially identical in the two sexes, exhibiting two-compartment model characteristics. However, the peripheral compartment volume of distribution of ceftazidime was smaller in the females (mean 3.95 liters, compared with 6.15 liters), and this was attributed to a smaller extracellular fluid volume. Eight volunteers in each group also received single 1-g doses of ceftazidime into the vastus lateralis and gluteus maximus muscles. The time to peak concentration was longer in the women, and it was longer after injection into the gluteus maximus in both sexes, presumably because of differences in local blood flow. The bioavailability of ceftazidime may have been slightly reduced by delays in absorption. Again, body and renal clearances were similar for both sexes when allowance was made for differences in distribution volume.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1975 Aug;18(2):215-20 - PubMed
    1. J Pharm Sci. 1976 Jul;65(7):1006-10 - PubMed
    1. J Antimicrob Chemother. 1979 Jan;5(1):87-93 - PubMed
    1. Antimicrob Agents Chemother. 1980 May;17(5):876-83 - PubMed
    1. Br J Clin Pharmacol. 1981 May;11(5):523-6 - PubMed

LinkOut - more resources